Physician profile

Ashlyn Ward

Optometrist · Urbandale, IA

NPI 1922587591

$879.91

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$260.53

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Coopervision INC. $315.24 2019-2024 Myday Contact Lens
Alcon Vision LLC $148.99 2021-2024 Dailies Total1, Total30, Precision 1
Johnson & Johnson Vision Care, INC. $131.50 2021-2024 Acuvue
Shire North American Group INC $115.74 2019
Bausch & Lomb Americas INC. $67.83 2023-2024 Infuse
Synergeyes, INC. $64.63 2019
Optos, INC. $23.42 2022
Novo Nordisk INC $12.56 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ashlyn Ward

$879.91

in general payments reported 2019-2025

Years
2019-2024
Top company
Coopervision INC.

https://glasscript.com/doctor/5230702/ashlyn-ward

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.